|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-3-14
|
|
pubmed:abstractText |
Bacterial resistance to currently available antimicrobials is an increasing concern, particularly among various gram-positive organisms such as drug-resistant pneumococci, methicillin-resistant staphylococci, and drug-resistant enterococci. Tigecycline is an investigational glycylcycline antibiotic that shows promising activity against these resistant gram-positive organisms.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0149-2918
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
12-22
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15763603-Animals,
pubmed-meshheading:15763603-Anti-Bacterial Agents,
pubmed-meshheading:15763603-Clinical Trials, Phase II as Topic,
pubmed-meshheading:15763603-Drug Resistance, Bacterial,
pubmed-meshheading:15763603-Drugs, Investigational,
pubmed-meshheading:15763603-Gram-Negative Bacteria,
pubmed-meshheading:15763603-Gram-Positive Bacteria,
pubmed-meshheading:15763603-Gram-Positive Bacterial Infections,
pubmed-meshheading:15763603-Humans,
pubmed-meshheading:15763603-Microbial Sensitivity Tests,
pubmed-meshheading:15763603-Minocycline
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
|
|
pubmed:affiliation |
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington 99210-1495, USA. garrism@wsu.edu
|
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|
